Rationale and Design of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy for Heart Failure (IMPACT-HF) Study

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 167-174

Karger

Access to resources Recommend Favorite

Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III – IV congestive heart failure

By Freudenberger Ronald S   Schwarz Jr Richard P   Brown Joanne   Moore Alan   Mann Douglas   Givertz Michael M   Colucci Wilson S   Hare Joshua M  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1509-1516

Informa Healthcare

Access to resources Recommend Favorite

Rationale and Design of a Randomized, Double-Blind, Placebo Controlled Multicenter Trial to Study Efficacy, Security, and Long Term Effects of Intermittent Repeated Levosimendan Administration in Patients with Advanced Heart Failure: LAICA study

By García-González Martín   Mora-Martín Manuel   López-Fernández Silvia   López-Díaz Javier   Martínez-Sellés Manuel   Romero-García José   Cordero Marco   Lara-Padrón Antonio   Marrero-Rodríguez Francisco   Mar García-Saiz M.   Aldea-Perona Ana  

Cardiovascular Drugs and Therapy, Vol. 27, Iss. 6, 2013-12 ,pp. : 573-579

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for the Use of Aldosterone Antagonists in Congestive Heart Failure

By Rocha R.  

Drugs, Vol. 62, Iss. 5, 2002-01 ,pp. : 723-731

Adis International

Access to resources Recommend Favorite